Detalles de la búsqueda
1.
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
J Infect Dis
; 228(3): 235-244, 2023 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883903
2.
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
Clin Infect Dis
; 76(3): e460-e468, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580849
3.
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Clin Infect Dis
; 77(4): 547-557, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37255285
4.
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
J Infect Dis
; 225(10): 1694-1700, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932114
5.
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
Clin Infect Dis
; 74(9): 1515-1524, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358310
6.
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
Clin Infect Dis
; 75(Suppl 2): S159-S166, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675695
7.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1625-1630, 2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36580424
8.
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1327-1334, 2022 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264830
9.
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(12): 459-465, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324878
10.
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
MMWR Morb Mortal Wkly Rep
; 71(4): 118-124, 2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085218
11.
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.
Clin Infect Dis
; 72(9): 1645-1648, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32628750
12.
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
Clin Infect Dis
; 73(8): 1459-1468, 2021 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014274
13.
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
Clin Infect Dis
; 73(Suppl 1): S32-S37, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33977301
14.
Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial.
Am Heart J
; 232: 116-124, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33144086
15.
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 674-679, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956782
16.
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
MMWR Morb Mortal Wkly Rep
; 70(38): 1337-1343, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34555004
17.
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
MMWR Morb Mortal Wkly Rep
; 70(34): 1156-1162, 2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34437524
18.
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
JAMA
; 326(20): 2043-2054, 2021 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734975
19.
Characteristics of Adult Outpatients and Inpatients with COVID-19 - 11 Academic Medical Centers, United States, March-May 2020.
MMWR Morb Mortal Wkly Rep
; 69(26): 841-846, 2020 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32614810
20.
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.
MMWR Morb Mortal Wkly Rep
; 69(30): 993-998, 2020 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32730238